GlassScriptPhysician profile
Barbara A Boreen
NPI 1184851966
$3,637.17
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,201 · 2022: $1,145 · 2023: $1,103 · 2024: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,290.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,000.22 | 2021-2024 | |
| Abbott Laboratories | $438.87 | 2021-2023 | Perclose Prostyle |
| Janssen Pharmaceuticals, INC | $378.16 | 2021-2023 | Xarelto |
| Irhythm Technologies, INC. | $248.15 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $175.59 | 2021-2023 | Repatha |
| Merck Sharp & Dohme LLC | $174.66 | 2021-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $150.39 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $141.57 | 2022-2023 | Eliquis |
| Esperion Therapeutics, INC. | $128.78 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.99 | 2021-2023 | Lifevest |
| Chiesi USA, INC. | $113.82 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $110.52 | 2021-2023 | Wainua, Farxiga |
| Daiichi Sankyo INC. | $68.67 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.86 | 2023 | Jardiance |
| Elutia, INC. | $39.96 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $39.75 | 2021-2023 | Cobalt Dr Mri Surescan |
| Pfizer INC. | $32.87 | 2022-2023 | |
| Astellas Pharma US INC | $31.28 | 2021 | |
| Bard Peripheral Vascular, INC. | $29.95 | 2022 | |
| Lantheus Medical Imaging, INC. | $29.05 | 2022 | |
| Abbvie INC. | $28.04 | 2021 | |
| Convatec INC. | $25.47 | 2022-2023 | |
| Veryan Medical Incorporated | $22.24 | 2023 | Biomimics 3d Vascular Stent System |
| Pharmacosmos Therapeutics INC. | $21.85 | 2021 | |
| Daxor Corporation | $16.46 | 2023 | Bva-100 |
| Boston Scientific Corporation | $15.59 | 2021 | |
| Cardiva Medical, INC. | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Boreen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.